Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on ...

In a phase 3 trial, 81% of wounds treated with autologous cell sheet-based gene therapy showed ≥ 50% healing at 6 months, ...

April 29, 2025Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.14.

That was over 10 years ago. The Block, which opened on Butter & Egg Days in 2017, just celebrated its eight-year anniversary.

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...

Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $8.22 EPS, expectations were $8.62. Operator: Welcome to the Regeneron ...

Turmeric might lower high blood pressure, but it depends on if you’re already on medication for blood pressure. Learn about ...